Schedule 13G ownership disclosure

Kyverna Therapeutics, Inc.

Security class unavailable · CUSIP: 501976104

Event date: 2024-02-12

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-24-040028
Form type
SC 13G
Filer
GILEAD SCIENCES, INC.
CIK
CIK 882095
Filed
Feb 20, 2024
Reporting period
Feb 12, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub